Naujausios naujienos ir straipsniai apie genetinius tyrimus
May 31, 2026
Salk Institute. "Estrogen-related receptors could be key to treating metabolic and muscular disorders." ScienceDaily. ScienceDaily, 13 May 2025. <www.sciencedaily.com/releases/2025/05/250512165549....
May 31, 2026
Researchers at the Salk Institute have identified estrogen-related receptors as a potential key to treating metabolic and muscular disorders. These receptors may play a crucial role in regulating various cellular processes, including metabolism and muscle function.
May 31, 2026
Researchers at the Salk Institute have identified estrogen-related receptors as potential targets for treating metabolic and muscular disorders. These receptors play a crucial role in regulating energy metabolism and muscle function.
May 31, 2026
A recent study published in a scientific journal has investigated the effectiveness of an anti-aging cream. The research team found that this topical treatment showed promising results in reducing signs of aging.
May 31, 2026
Scientists have conducted an experiment to evaluate the efficacy of a topical cream that claims to slow down skin aging. The results suggest that this cream may indeed have anti-aging effects.
May 31, 2026
Researchers have tested a novel anti-aging cream that has shown promising results in reducing signs of skin aging. The product's efficacy was evaluated through clinical trials, and its potential as a non-invasive treatment option for age-related skin concerns.
May 30, 2026
Researchers at NYU Langone Health have developed a gene-based blood test that may help detect early signs of melanoma recurrence. This non-invasive test has the potential to improve patient outcomes by identifying cancer return before symptoms appear.
May 30, 2026
Researchers have developed a gene-based blood test that may help detect early signs of melanoma recurrence. This innovative approach could potentially improve patient outcomes by enabling earlier intervention.
May 30, 2026
Researchers at NYU Langone Health have developed a gene-based blood test that may identify early signs of melanoma recurrence. This innovative diagnostic tool has the potential to improve treatment outcomes and patient survival.
